Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Rheumatology and Therapy|November 28, 2022
Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid ArthritisStanley Cohen, Jeffrey R Curtis, Theodore Mellors, et al.
The Journal of Rheumatology|April 3, 2008
Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritisPrabha Ranganathan, Robert Culverhouse, Sharon Marsh, et al.
Rheumatology and Therapy|February 9, 2018
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc AnalysisRoy Fleischmann, Jürgen Wollenhaupt, Stanley Cohen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 30, 2023
A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid ArthritisMatthew C Baker, Sarah Kavanagh, Stanley Cohen, et al.
Rheumatology and Therapy|March 28, 2019
Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled TrialStanley Cohen, Ahmed Samad, Elaine Karis, et al.
The Journal of Rheumatology|March 3, 2010
Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRISE trialPhilip J Mease, Stanley Cohen, Norman B Gaylis, et al.
The Journal of Rheumatology|June 3, 2009
Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trialS Aubrey Stoch, Kenneth G Saag, Maria Greenwald, et al.
Applied and Environmental Microbiology|December 5, 2006
Characterization of a large, stable, high-copy-number Streptomyces plasmid that requires stability and transfer functions for heterologous polyketide overproductionRyan Fong, Jonathan A Vroom, Zhihao Hu, et al.
Arthritis Research & Therapy|March 29, 2020
Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritisMark C Genovese, Juan Sanchez-Burson, MyungShin Oh, et al.
Arthritis and Rheumatism|March 29, 2002
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trialStanley Cohen, Eric Hurd, John Cush, et al.
Pageof 11